Skip to main content
. 2021 May 26;9(6):555. doi: 10.3390/vaccines9060555

Figure 1.

Figure 1

In vitro evaluation of BZLF1 immunogen through DC: PBMC CoCx, followed by HLA-pentamer loaded with BZLF1 RAK peptide and flow cytometry; (A) Schematic of the CoCx experiments; (B) Gating scheme for pentamer flow data; (C) viSNE immunome maps that show distinct clusters representing different immune cell types; (D) Frequency of RAK+ T-cells from PBMCs, αDEC205-Ctrl CoCx, and αDEC205-BZLF CoCx across 4 HLA-B8 donors; (E) Absolute count of RAK+ T-cells from PBMCs, αDEC205-Ctrl CoCx, and αDEC205-BZLF CoCx across 4 HLA-B8 donors.